985
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Development and optimisation of atorvastatin calcium loaded self-nanoemulsifying drug delivery system (SNEDDS) for enhancing oral bioavailability: in vitro and in vivo evaluation

, &
Pages 319-333 | Received 13 Dec 2016, Accepted 05 May 2017, Published online: 23 May 2017

References

  • Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, Aggarwal BB. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol, 2010;79:330–8.
  • Badran MM, Taha EI, Tayel MM, Al-Suwayeh SA. Ultra-fine self nanoemulsifying drug delivery system for transdermal delivery of meloxicam: Dependency on the type of surfactants. J Mol Liq, 2014;190:16–22.
  • Balakumar K, Raghavan CV, Selvan NT, Prasad RH, Abdu S. Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: Design, formulation, bioavailability and pharmacokinetic evaluation. Colloids Surf B Biointerfaces, 2013;112:337–43.
  • Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: Development and optimization. Int J Pharm, 2010;391:203–11.
  • Borhade V, Pathak S, Sharma S, Patravale V. Clotrimazole nanoemulsion for malaria chemotherapy. Part I: Preformulation studies, formulation design and physicochemical evaluation. Int J Pharm, 2012;431:138–48.
  • Chen Y, Li G, Wu X, Chen Z, Hang J, Qin B, Chen S, Wang R. Self-Microemulsifying Drug Delivery System (SMEDDS) of vinpocetine: Formulation development and in vivo assessment. Biol Pharm Bull, 2008;31:118–25.
  • Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm, 2007;329:166–72.
  • Elnaggar YS, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: Design and optimization. Int J Pharm, 2009;380:133–41.
  • Hill LE, Gomes C, Taylor TM. Characterization of beta-cyclodextrin inclusion complexes containing essential oils (trans-cinnamaldehyde, eugenol, cinnamon bark, and clove bud extracts) for antimicrobial delivery applications. LWT – Food Sci Technol, 2013;51:86–93.
  • Hunter RJ. Zeta potential in colloid science: Principles and applications. London: Academic Press; 1981.
  • Hussein AK, Ibrahim MA, Amin MA, Ahmed OAA. Improved in vitro dissolution parameters and in vivo hypolipidemic efficiency of atorvastatin calcium through the formation of hydrophilic inclusion complex with cyclodextrins. Drug Dev Res, 2011;72:379–90.
  • Ibrahim HM, Ahmed TA, Hussain MD, Rahman Z, Samy AM, Kaseem AA, Nutan MT. Development of meloxicam in situ implant formulation by quality by design principle. Drug Dev Ind Pharm, 2014;40:66–73.
  • Jain S, Jain AK, Pohekar M, Thanki K. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: Implications for drug-induced cardiotoxicity and nephrotoxicity. Free Radic Biol Med, 2013;65:117–30.
  • Kim JS, Kim MS, Park HJ, Jin SJ, Lee S, Hwang SJ. Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process. Int J Pharm, 2008a;359:211–9.
  • Kim MS, Jin SJ, Kim JS, Park HJ, Song HS, Neubert RH, Hwang SJ. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm, 2008b;69:454–65.
  • Krishnamoorthy B, Habibur Rahman SM, Tamil Selvan N, Hari Prasad R, Rajkumar M, Siva Selvakumar M, Vamshikrishna K, Gregory M, Vijayaraghavan C. Design, formulation, in vitro, in vivo, and pharmacokinetic evaluation of nisoldipine-loaded self-nanoemulsifying drug delivery system. J Nanopart Res, 2015;17:1–11.
  • Lennernas H. Clinical pharmacokinetics of atorvastatin. Clin Pharmacokinet, 2003;42:1141–60.
  • Li P, Ghosh A, Wagner RF, Krill S, Joshi YM, Serajuddin AT. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int J Pharm, 2005;288:27–34.
  • Liu Y, Zhang P, Feng N, Zhang X, Wu S, Zhao J. Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int J Pharm, 2009;365:136–42.
  • Marasini N, Yan YD, Poudel BK, Choi HG, Yong CS, Kim JO. Development and optimization of self-nanoemulsifying drug delivery system with enhanced bioavailability by Box–Behnken design and desirability function. J Pharm Sci, 2012;101:4584–96.
  • Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care, 2013;40:195–211.
  • Nepal PR, Han HK, Choi HK. Preparation and in vitro–in vivo evaluation of Witepsol H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q(10). Eur J Pharm Sci, 2010;39:224–32.
  • Niczinger NA, Kallai-Szabo N, Dredan J, Budai L, Hajdu M, Antal I. Application of droplet size analysis for the determination of the required HLB of lemon oil in O/W emulsion. Curr Pharm Anal, 2014;11:11–5.
  • Sánchez MC, Berjano M, Guerrero A, Gallegos C. Emulsification rheokinetics of nonionic surfactant-stabilized oil-in-water emulsions. Langmuir, 2001;17:5410–6.
  • Shakeel F, Iqbal M, Ezzeldin E. Bioavailability enhancement and pharmacokinetic profile of an anticancer drug ibrutinib by self-nanoemulsifying drug delivery system. J Pharm Pharmacol, 2016;68:772–80.
  • Shende P, Deshmukh K, Trotta F, Caldera F. Novel cyclodextrin nanosponges for delivery of calcium in hyperphosphatemia. Int J Pharm, 2013;456:95–100.
  • Tiwari R, Pathak K. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: Comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm, 2011;415:232–43.
  • Verma S, Singh SK, Verma PR, Ahsan MN. Formulation by design of felodipine loaded liquid and solid self nanoemulsifying drug delivery systems using Box–Behnken design. Drug Dev Ind Pharm, 2014;40:1358–70.
  • Vila L, Rebollo A, Adalsteisson GS, Alegret M, Merlos M, Roglans N, Laguna JC. Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment. Toxicol Appl Pharmacol, 2011;251:32–40.
  • Villar AM, Naveros BC, Campmany AC, Trenchs MA, Rocabert CB, Bellowa LH. Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for enhanced dissolution of gemfibrozil. Int J Pharm, 2012;431:161–75.
  • Wang L, Dong J, Chen J, Eastoe J, Li X. Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci, 2009;330:443–8.
  • Warisnoicharoen W, Lansley AB, Lawrence MJ. Nonionic oil-in-water microemulsions: The effect of oil type on phase behaviour. Int J Pharm, 2000;198:7–27.
  • WHO. 2008. Raised cholesterol [Online] Available at: http://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/. Accessed December 2016.
  • Zhang HX, Wang JX, Zhang ZB, Le Y, Shen ZG, Chen JF. Micronization of atorvastatin calcium by antisolvent precipitation process. Int J Pharm, 2009;374:106–13.
  • Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int J Pharm, 2008;355:269–76.
  • Zhu S, Hong M, Liu C, Pei Y. Application of Box–Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation. Pharm Dev Technol, 2009;14:642–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.